|
HS Code |
737893 |
| generic_name | Estradiol |
| drug_class | Estrogens |
| molecular_formula | C18H24O2 |
| molecular_weight | 272.38 g/mol |
| route_of_administration | Oral, transdermal, vaginal, injectable |
| indications | Hormone replacement therapy, menopausal symptoms, hypoestrogenism, gender-affirming therapy |
| mechanism_of_action | Binds to estrogen receptors inducing gene transcription |
| CAS_number | 50-28-2 |
| ATC_code | G03CA03 |
As an accredited Estradiol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White cardboard box containing 10mg Estradiol tablets, blister-packed, clearly labeled with dosage, manufacturer, batch number, and expiry date. |
| Shipping | Estradiol is shipped in tightly sealed, clearly labeled containers, compliant with regulatory and safety standards. It is transported under controlled temperatures to ensure stability and prevent degradation. Proper documentation accompanies each shipment, including safety data sheets. Handling precautions are strictly followed to minimize risks during transit and delivery. |
| Storage | Estradiol should be stored in a tightly closed container, away from light and moisture, at a controlled room temperature of 20–25°C (68–77°F). Avoid exposure to heat, humidity, and incompatible substances such as strong oxidizers. Keep the container in a secure, well-ventilated area, and ensure it is clearly labeled. Store out of reach of unauthorized personnel and children. |
| Purity 98%: Estradiol Purity 98% is used in hormone replacement therapy, where it ensures consistent and reliable estrogen supplementation. Micronized Particle Size: Estradiol Micronized Particle Size is used in oral tablet formulations, where it allows improved gastrointestinal absorption and bioavailability. Melting Point 178°C: Estradiol Melting Point 178°C is used in transdermal patches, where it supports formulation stability during manufacturing and storage. Stability Temperature 25°C: Estradiol Stability Temperature 25°C is used in topical creams, where it maintains chemical integrity through shelf life. USP Grade: Estradiol USP Grade is used in pharmaceutical compounding, where it guarantees compliance with regulatory quality standards. Molecular Weight 272.38 g/mol: Estradiol Molecular Weight 272.38 g/mol is used in intravenous formulations, where it provides precise dosing and predictable pharmacokinetics. Water Solubility 0.002 mg/mL: Estradiol Water Solubility 0.002 mg/mL is used in sustained-release injectables, where it modulates drug release rates for prolonged effect. Endotoxin Level <0.5 EU/mg: Estradiol Endotoxin Level <0.5 EU/mg is used in sterile injectable products, where it minimizes risk of pyrogenic reactions. Residual Solvents <0.05%: Estradiol Residual Solvents <0.05% is used in medical device coatings, where it ensures biocompatibility and patient safety. Isomeric Purity >99%: Estradiol Isomeric Purity >99% is used in hormone assays, where it contributes to accurate analytical reference standards. |
Competitive Estradiol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Healthcare has many crossroads where science, experience, and trust meet. Estradiol stands as one of those bridges. Over the years, I have witnessed countless patients sitting across from me, uneasy, often searching for relief from hormone imbalance, menopause symptoms, or the complicated fallout of certain surgeries. Estradiol has played a big role for many, shaping the daily lives of people who count on reliable treatment options. Drawing from its track record and my own hands-on interactions, thoughts on this product always circle back to how it meets actual needs, rather than sitting on a shelf as another pharmaceutical.
We live in a world where health information moves fast, sometimes too fast for people to keep up. Seeing patients sift through seemingly endless options, the value of clarity and tried-and-true solutions stands out. Estradiol has long served as a foundation of hormone therapy for women managing menopause. Those sudden flushes, night sweats, and mood swings are not just passing discomforts; they affect work, relationships, and mental well-being. Estradiol steps in as a tool to bring those moments of equilibrium back, improving day-to-day living in ways that's easy to take for granted unless you or someone close has faced hormone loss.
Beyond menopause, estradiol reaches people recovering from surgeries that disrupt natural hormone production, those dealing with primary ovarian insufficiency, or those who pursue hormone therapy for gender-affirming care. I remember interacting with patients who felt isolated by their symptoms until we discussed adding estradiol to their treatment plan. Their relief—a mix of hope and regained confidence—spoke louder than any sales pitch.
Estradiol’s flexibility stands out right away. Tablets mark the most familiar route, sitting in the medicine cabinet alongside vitamins and aspirin. Patches become a quiet companion on the skin, releasing a steady dose over days, freeing patients from daily pills and providing fewer ups and downs in hormone levels. Topical gels and creams answer the call for those looking for alternatives that avoid the digestive tract or who struggle with pill fatigue. For others, injections or implants might match their circumstances, especially in cases that call for higher or more sustained levels.
Conversations often lead to the rhythm of absorption and the speed with which estradiol does its work. With patches or topical applications, there’s less stress on liver function, a factor that makes a difference over years of therapy. Some see the avoidance of first-pass metabolism as a big bonus, especially patients with specific health concerns. Oral routes, though simpler in some settings, place higher load on the liver with each dose, a point to consider as part of the broader health picture.
There’s more to estradiol than a generic description. I dive into specifics every time I help someone weigh their options. For example, typical estradiol tablets range through doses such as 0.5 mg, 1 mg, or 2 mg, allowing fine-tuning. Transdermal patches offer strengths from 0.025 mg to 0.1 mg released per 24 hours, giving flexibility based on response and goals. Each approach brings not just numbers, but different side effect profiles and convenience factors with them.
Formulation and purity gain extra weight for anyone relying on consistent hormone levels. Some people respond better to micronized estradiol, which is more easily absorbed and mirrors the body’s own processes. Patients report fewer ups and downs in symptoms when products stick to these higher manufacturing standards, and blood work often backs up these observations. I have seen marked improvement in well-being simply by changing delivery methods or ensuring the right formulation is being used.
The hormone therapy landscape is not a flat playing field. People sometimes ask about the difference between estradiol and conjugated estrogens, or wonder if plant-based “phytoestrogens” can work just as well for their needs. Estradiol holds a special status because it matches what the human body produces before hormone levels drop. This true-molecule approach translates into steady results, predictable side effect profiles, and easier monitoring.
Conjugated estrogens bring together a mix of molecules, some of which the body doesn’t naturally make in high amounts. This mix can widen side effect possibilities and make dose customization tougher. Some patients prefer plant-based alternatives, hoping for a “gentler” route, though most research doesn’t back up that expectation for strong symptoms. Over-the-counter phytoestrogen products often fail to match the power or reliability of prescription products like estradiol.
Experience on the front lines of care has shown me where pitfalls wait. Estradiol, like any hormone therapy, comes with warnings that need respect. Clotting risk, breast and uterine health, and cardiovascular concerns—these stay in focus through regular follow-up and skilled decision-making. I recall more than one occasion where routine lab checks caught a brewing problem early, allowing us to adjust the plan before complications took root.
Long-term data drives home the point: hormone therapy can increase the risk of certain cancers and blood clots but also protects bone health and lessens the intensity of menopausal symptoms. Women who take estradiol for a shorter time, and who keep doses as low as possible, gain more of the benefits while lowering risks. Shared decision-making, honest talk about personal and family health history, and regular screenings combine to keep things safe.
In the exam room or over the phone, stories from real life fill in the blanks often left by data. I have watched how simple choices—patch over pill, skipping a dose, or missing regular follow-up—play out months or years down the line. Reminders about patch application technique, written logs for symptoms, and gentle check-ins to keep patients on track may add up to better outcomes than any dosage adjustment.
Convenience and cost shape daily adherence more than most people realize. Insurers often set limits based on price, nudging people toward one form over another. I have seen some patients thrive on simple tablets, while others found freedom and comfort only after switching to a patch or gel. The beauty of estradiol lies in having a menu of choices to fit daily life, jobs, habits, and priorities.
Hormone balance doesn't just smooth out hot flashes or night sweats; it ripples through bone strength, sleep quality, sexual health, and mood stability. Younger women thrown into early menopause—by nature or by surgery—often need a well-tuned estradiol plan more urgently. Their challenges go beyond simple symptoms, touching on issues like osteoporosis risk, heart health, and even self-image. Estradiol, when used thoughtfully and under watchful care, restores more than hormone levels; it brings back choices taken away by illness or time.
Men seeking hormone therapy as part of gender-affirming care bring their own unique challenges and goals. Doses, monitoring, and delivery methods require precise adjustments, often guided by both research and lived expertise from the community. I have worked with countless patients in these circumstances who stressed the need for respect, dignity, and consistency in their regimen—values echoed in the flexibility and scientific stability of estradiol.
We can’t avoid the impact of clinical studies and regulatory oversight, which offer a safety net of sorts. The FDA and similar bodies shape which forms of estradiol reach the pharmacy shelf, relying on years of data rather than quick fixes. Large studies comparing estradiol to alternatives show that its effects on common menopause symptoms beat over-the-counter options and unstandardized compounded mixtures. The evidence also shows how the route of administration can influence side effect development. For instance, transdermal estradiol carries a lower risk of blood clots than oral forms—a difference that matters to women with risk factors for vascular events.
Patient stories weave the rest. It is not uncommon to hear relief in someone’s voice after months spent looking for answers. Many return after starting estradiol with newfound sleep, energy, and improved relationships. There are moments of setback too—side effects, unexpected test results, or changes that call for starting over. Skillful use of estradiol means marrying the data with the lived realities of each person.
Use of estradiol, much like any other long-term medication, sometimes stumbles over barriers that have nothing to do with medicine. Societal attitudes toward hormone therapy have shifted, often swinging between overzealous use and unwarranted fear. The results of past studies, such as the Women’s Health Initiative, left a mixed legacy with some losing trust in these products. This created confusion and, in some cases, led women who might benefit from estradiol to avoid asking about it at all.
Access too poses a hurdle. Insurance approval, pharmacy shortages, or confusing regulations at the state and national level can leave patients in the lurch. For patients in smaller communities, finding a provider who is comfortable with the newest evidence might feel like looking for a needle in a haystack. I’ve seen people go through unnecessary discomfort because bureaucracy stood taller than common sense.
Education remains the strongest ally. If I have learned anything from years of patient care and research, it’s that equipping people with plain answers—plus a roadmap of what to expect—beats scare tactics or jargon. Sharing key facts, such as the variety of estradiol formats or the real numbers on risks, brings a kind of empowerment that pays off in fewer surprises down the road.
System improvements have their place, too. Regular reminders for screening and monitoring, more flexible insurance policies, and a willingness among medical providers to update their knowledge make a real difference. On a community level, breaking down taboos and placing hormone therapy in everyday conversation can help people find their footing, whether they are starting therapy for the first time or considering a change from another medication. Reliable, updated public resources with plain-language explanations on hormone therapy could bridge the information gap that powers so much worry and confusion.
The way we use and talk about estradiol continues to evolve. As research grows and more is understood about the long-term effects of hormone therapy, new delivery systems, or the subtleties of dosing, healthcare providers and patients gain better tools. Personalized care, where someone’s life story becomes as important as their lab results, stands as the current gold standard.
A few trends float to the surface. Microdosing—starting at lower levels and climbing slowly—has helped some avoid side effects. Extended-release patches and tailored gels speak to a market that prizes flexibility more each year. Home monitoring, digital reminders, and telemedicine platforms blend convenience with security, making it easier for people to fit therapy into busy lives.
Personal experience, along with ongoing conversations in support groups and advocacy spaces, has highlighted one thing: connection counts. Sharing knowledge and challenges among families, caregivers, and friends builds a network of emotional and practical support that no product description can replace. Health, after all, thrives best where information and empathy come together.
Estradiol will likely remain an anchor product for many in hormone therapy settings, not because it’s a miracle cure, but because it provides solid, predictable results for a wide range of people. Good care takes more than just picking the right medication. Addressing stress, nutrition, sleep, and mental health—in partnership with any hormone plan—sets the stage for real, lasting comfort and improvement.
Standing as both a healthcare provider and a witness to the everyday victories and losses tied to hormone therapy, my appreciation for estradiol comes from what I see in the real world. The gratitude from a woman who gets her nights back after months of insomnia, the student able to focus in class without interruptions from hot flashes, or the trans person finally feeling like their inside matches their outside—these are the moments that define the product’s role far more than anything printed on a package insert.
Problems can and do emerge—missed doses, insurance hurdles, or setbacks in therapy. Every episode of frustration kicks off another round of innovation or advocacy, further shaping the way estradiol gets used by real people, not just trial subjects. The ongoing dialogue between patient and provider, backed by updated evidence, brings constant refinement to how we harness the benefits while minimizing the risks.
Estradiol, by its nature and its history, works at the intersection of human need, evolving science, and ethical responsibility. Unlike many products, it doesn’t fade into the background after a prescription is written. Instead, it thrives—and sometimes falters—based on how thoroughly patients, providers, and the broader health system commit to ongoing, open conversations and a shared quest for balance.
Choosing an estradiol product—tablet, patch, gel, or another form—goes beyond matching symptoms with a bottle. It means respecting unique preferences, anticipating challenges, and welcoming change as fresh data and patient voices shape what comes next. I trust that continued engagement and transparency will keep estradiol not just relevant, but reliably helpful for those who count on it most, paving a better path for the next wave of people facing hormone loss or imbalance.